Gara Jalqabaatti › Lymphoma T-Cell Dhiyaataa
Qorannoo klinikaalii Lymphoma T-Cell Dhiyaataa Ameerikaa Keessatti hirmaatuu
Qorannoo 20 Lymphoma T-Cell Dhiyaataa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 9
- New York City, NYQorannoo 6
- Boston, MAQorannoo 5
- Baldwin Park, CAQorannoo 5
- Philadelphia, PAQorannoo 4
- Atlanta, GAQorannoo 4
- Columbus, OHQorannoo 3
- Ann Arbor, MIQorannoo 3
- Aurora, COQorannoo 3
Naannoon
- CaliforniaQorannoo 8
- ColoradoQorannoo 3
- FloridaQorannoo 4
- GeorgiaQorannoo 4
- MarylandQorannoo 3
- MassachusettsQorannoo 5
- MichiganQorannoo 5
- New JerseyQorannoo 3
- New YorkQorannoo 7
- OhioQorannoo 5
- PennsylvaniaQorannoo 6
- TexasQorannoo 10
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07388563Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04234048Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06176690Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07192471Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06561048A Phase II, Single-center, Single-arm Study Evaluating the Safety and Efficacy of Golidocitinib in the Management of Newly Diagnosed Peripheral T Cell Lymphoma Patients (GOLDEN Study) and Correlative Study
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06630091CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT04083495A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07195916AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06137144Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 1 hanga 31 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT03719105Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07750886A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT04045470To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06072131Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06508463Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT04068597Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05313243Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT07356245Amping up With PemJAK
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 95 · Saalaa hunda · Haaromfame 16-Mud-2025 · NCT07283822Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2025 · NCT03964480Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.